Exogenous Pro-Angiogenic Stimuli Cannot Prevent Physiologic Vessel Regression

Journal of Surgical Research

Volumn 135, Issue 2, 2006, Pages 218-225

  Gosain, Ankush ^a   Matthies, Annette M ^a   Dovi, Julia V ^a   Barbul, Adrian ^b   Gamelli, Richard L ^a   DiPietro, Luisa A ^c  

^a LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

^b SINAI HOSPITAL OF BALTIMORE   (United States)

^c UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

angiogenesis; regression; VEGF, FGF, PDGF; wound

Indexed keywords

FIBROBLAST GROWTH FACTOR 2; GROWTH FACTOR; RECOMBINANT PLATELET DERIVED GROWTH FACTOR; RECOMBINANT VASCULOTROPIN;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL; CONTROLLED STUDY; FEMALE; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; OSMOTIC PUMP; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; WOUND; WOUND HEALING;

ANALYSIS OF VARIANCE; ANGIOGENESIS INDUCING AGENTS; ANIMALS; BLOOD VESSELS; FEMALE; FIBROBLAST GROWTH FACTORS; IMMUNOHISTOCHEMISTRY; MICE; MICE, INBRED BALB C; PLATELET-DERIVED GROWTH FACTOR; VASCULAR ENDOTHELIAL GROWTH FACTOR A; WOUND HEALING;

EID: 33748774920     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2006.04.006     Document Type: Article

References (36)

1. Ferrara N. Role of vascular endothelial growth factor in regulation of physiological angiogenesis. Am J Physiol Cell Physiol 280 (2001) C1358
2. Nissen N.N., Polverini P.J., Koch A.E., Volin M.V., Gamelli R.L., and DiPietro L.A. Vascular endothelial growth factor mediates angiogenic activity during the proliferative phase of wound healing. Am J Pathol 152 (1998) 1445
3. Ferrara N., Chen H., Davis-Smyth T., et al. Vascular endothelial growth factor is essential for corpus luteum angiogenesis. Nat Med 4 (1998) 336
4. Howdieshell T.R., Callaway D., Webb W.L., et al. Antibody neutralization of vascular endothelial growth factor inhibits wound granulation tissue formation. J Surg Res 96 (2001) 173
5. Matthies A.M., Low Q.E., Lingen M.W., and DiPietro L.A. Neuropilin-1 participates in wound angiogenesis. Am J Pathol 160 (2002) 289
6. Swift M.E., Kleinman H.K., and DiPietro L.A. Impaired wound repair and delayed angiogenesis in aged mice. Lab Invest 79 (1999) 1479
7. Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1 (1995) 27
8. Alon T., Hemo I., Itin A., Pe'er J., Stone J., and Keshet E. Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity. Nat Med 1 (1995) 1024
9. Giavazzi R., Sennino B., Coltrini D., et al. Distinct role of fibroblast growth factor-2 and vascular endothelial growth factor on tumor growth and angiogenesis. Am J Pathol 162 (2003) 1913
10. Benjamin L.E., Golijanin D., Itin A., Pode D., and Keshet E. Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal. J Clin Invest 103 (1999) 159
11. Nissen N.N., Polverini P.J., Gamelli R.L., and DiPietro L.A. Basic fibroblast growth factor mediates angiogenic activity in early surgical wounds. Surgery 119 (1996) 457
12. Stavri G.T., Zachary I.C., Baskerville P.A., Martin J.F., and Erusalimsky J.D. Basic fibroblast growth factor upregulates the expression of vascular endothelial growth factor in vascular smooth muscle cells. Synergistic interaction with hypoxia. Circulation 92 (1995) 11
13. Tomanek R.J., Lotun K., Clark E.B., Suvarna P.R., and Hu N. VEGF and bFGF stimulate myocardial vascularization in embryonic chick. Am J Physiol 274 (1998) H1620
14. Heldin C.H. Structural and functional studies on platelet-derived growth factor. Embo J 11 (1992) 4251
15. Efron D.T., Most D., Shi H.P., Tantry U.S., and Barbul A. A novel method of studying wound healing. J Surg Res 98 (2001) 16
16. Goto F., Goto K., Weindel K., and Folkman J. Synergistic effects of vascular endothelial growth factor and basic fibroblast growth factor on the proliferation and cord formation of bovine capillary endothelial cells within collagen gels. Lab Invest 69 (1993) 508
17. Jang Y.C., Arumugam S., Gibran N.S., and Isik F.F. Role of alpha (v) integrins and angiogenesis during wound repair. Wound Repair Regen 7 (1999) 375
18. Risau W. Mechanisms of angiogenesis. Nature 386 (1997) 671
19. Larcher F., Murillas R., Bolontrade M., Conti C.J., and Jorcano J.L. VEGF/VPF overexpression in skin of transgenic mice induces angiogenesis, vascular hyperpermeability and accelerated tumor development. Oncogene 17 (1998) 303
20. Yano K., Brown L.F., and Detmar M. Control of hair growth and follicle size by VEGF-mediated angiogenesis. J Clin Invest 107 (2001) 409
21. Supp D.M., and Boyce S.T. Overexpression of vascular endothelial growth factor accelerates early vascularization and improves healing of genetically modified cultured skin substitutes. J Burn Care Rehabil 23 (2002) 10
22. Vale P.R., Isner J.M., and Rosenfield K. Therapeutic angiogenesis in critical limb and myocardial ischemia. J Interv Cardiol 14 (2001) 511
23. Carmeliet P. Angiogenesis in health and disease. Nat Med 9 (2003) 653
24. Carmeliet P., Ferreira V., Breier G., et al. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 380 (1996) 435
25. Shalaby F., Rossant J., Yamaguchi T.P., et al. Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice. Nature 376 (1995) 62
26. Nor J.E., Mitra R.S., Sutorik M.M., Mooney D.J., Castle V.P., and Polverini P.J. Thrombospondin-1 induces endothelial cell apoptosis and inhibits angiogenesis by activating the caspase death pathway. J Vasc Res 37 (2000) 209
27. Luster A.D., Cardiff R.D., MacLean J.A., Crowe K., and Granstein R.D. Delayed wound healing and disorganized neovascularization in transgenic mice expressing the IP-10 chemokine. Proc Assoc Am Physicians 110 (1998) 183
28. Albini A., Marchisone C., Del Grosso F., et al. Inhibition of angiogenesis and vascular tumor growth by interferon-producing cells: A gene therapy approach. Am J Pathol 156 (2000) 1381
29. Ehrbar M., Djonov V.G., Schnell C., et al. Cell-demanded liberation of VEGF121 from fibrin implants induces local and controlled blood vessel growth. Circ Res 94 (2004) 1124
30. Bernstein L.R., Antoniades H., and Zetter B.R. Migration of cultured vascular cells in response to plasma and platelet-derived factors. J Cell Sci 56 (1982) 71
31. D'Amore P.A., and Smith S.R. Growth factor effects on cells of the vascular wall: A survey. Growth Factors 8 (1993) 61
32. Leveen P., Pekny M., Gebre-Medhin S., Swolin B., Larsson E., and Betsholtz C. Mice deficient for PDGF B show renal, cardiovascular, and hematological abnormalities. Genes Dev 8 (1994) 1875
33. Lindahl P., Johansson B.R., Leveen P., and Betsholtz C. Pericyte loss and microaneurysm formation in PDGF-B-deficient mice. Science 277 (1997) 242
34. Buzney S.M., Frank R.N., Varma S.D., Tanishima T., and Gabbay K.H. Aldose reductase in retinal mural cells. Invest Ophthalmol Vis Sci 16 (1977) 392
35. Bergers G., Song S., Meyer-Morse N., Bergsland E., and Hanahan D. Benefits of targeting both pericytes and endothelial cells in the tumor vasculature with kinase inhibitors. J Clin Invest 111 (2003) 1287
36. Song S., Ewald A.J., Stallcup W., Werb Z., and Bergers G. PDGFRbeta+ perivascular progenitor cells in tumours regulate pericyte differentiation and vascular survival. Nat Cell Biol 7 (2005) 870